# Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight Subjects

> **NCT04375696** · PHASE4 · COMPLETED · sponsor: **Certmedica International GmbH** · enrollment: 150 (actual)

## Conditions studied

- Weight Loss

## Interventions

- **DRUG:** Polyglucosamine L112
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04375696
- **Lead sponsor:** Certmedica International GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-24
- **Primary completion:** 2021-12-20
- **Final completion:** 2021-12-20
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2022-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04375696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04375696, "Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04375696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*